Blog: Cancer
- Cancer Survivors New Clinical Practice Guidelines Issued 2013
March 22, 2017
Read MoreCancer Survivors: New Clinical Practice Guidelines Issued 2013 According to the National Cancer Institute (NCI), there are more than 12 million American cancer survivors. Recognizing and managing the health care needs of these survivors has become a significant responsibility of oncologists and primary care providers. An individual is considered a cancer survivor from the time […]
- Annaul Ct Scans Can Reduce Lung Cancer Deaths
March 22, 2017
Read MoreAnnual CT scans can reduce lung cancer deaths A new study by the National Cancer Institute has found that yearly CT scans of current and former heavy smokers reduce the risk that they will die from lung cancer by 20 percent, and even seemed to reduce their risk of death from other causes also. “This […]
- Endometrial Cancer Screening
March 22, 2017
Read MoreEndometrial cancer screening Endometrial cancer is the most common gynecologic cancer among women in the United States and Europe. Amazingly, the medical community in the United States has not recommended broad-based screening for this common cancer. But a newly published British study shows that screening for this cancer can be feasible by using transvaginal ultrasound. […]
- Early Detection Of Cancer Of Esophagus New Alternative To Endoscopy
March 22, 2017
Read MoreEarly detection of cancer of esophagus — new alternative to endoscopy Barrett’s esophagus is an alteration of the esophageal tissue and can occur in people who have had heartburn over a considerable period of time. It is the main risk factor for esophageal cancer. A significant number of those who develop Barrett’s esophagus (about 10%) […]
- Prostate Cancer Xofigo Is A New Drug For Late Stage Prostate Cancer
March 22, 2017
Read MoreProstate Cancer — Xofigo Is A New Drug for Late Stage Prostate Cancer Xofigo is a drug newly approved by the FDA for late stage prostate cancer which has the potential to extend life by about 3 months. The drug treats symptomatic, late-stage, castration-resistant prostate cancer. Xofigo (radium Ra 223 dichloride) is approved for patients who […]
- Prostate Cancer Diagnosis Affected By Common Medicines
March 22, 2017
Read MoreProstate Cancer Diagnosis Affected by Common Medicines Commonly prescribed medicines can alter results of PSA cancer screening tests, making the test results artificially low when the actual PSA levels are higher. A research study reveals that men regularly consuming NSAIDs [non-steroidal anti-inflammatory drugs], statins, and thiazide diuretics may have lower serum PSA levels compared to […]
- New Treatment For Advanced Prostate Cancer
March 22, 2017
Read MoreNew Treatment for Advanced Prostate Cancer Advanced prostate cancer patients treated with cabazitaxel achieved significantly longer overall survival than did those treated with mitoxantrone. The clinical study sought to find the best treatment for patients with advanced disease after they have completed docetaxel treatment. Up until now, doctors have used various treatments at this stage […]
- Length Of Fingers Can Indicate Risk Of Prostate Cancer Say British Scientists
March 22, 2017
Read MoreLength of fingers can indicate risk of prostate cancer say British scientists A man whose index finger is longer than his ring finger has a statistically one-third lower risk of developing prostate cancer compared to those whose index fingers are shorter than their ring fingers, scientists report in the British Journal of Cancer. The […]
- Blood Test Accurately Predicts Death From Prostate Cancer Up To 25 Years In Advance
March 22, 2017
Read MoreBlood test Accurately Predicts Death from Prostate Cancer up to 25 Years in Advance A blood test at the age of 60 can accurately predict the risk that a man will die from prostate cancer within the next 25 years, according to researchers at Memorial Sloan-Kettering Cancer Center, in New York, and Lund University, in […]
- New Prostate Cancer Drug Treatment May Increase Survival Time
March 22, 2017
Read MoreNew Prostate Cancer Drug Treatment May Increase Survival Time Prostate cancer is the second most common cancer in men. New findings are that men diagnosed with advanced cases may live up to four months longer by taking a new chemotherapy drug. The drug is called Cabazitaxel. Cabazitaxel is the first drug to show a survival […]